share_log
Moomoo 24/7 ·  Apr 22 09:38
Madrigal Pharmaceuticals Inc : BofA Global Research Initiates Coverage With Underperform Rating; Price Objective $150
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment